Cite
HARVARD Citation
Demoly, P. et al. (2015). Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clinical and translational allergy. 5 (1), pp. 1-17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Demoly, P. et al. (2015). Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clinical and translational allergy. 5 (1), pp. 1-17. [Online].